| mRNA |
linifanib |
GDSC1000 |
pan-cancer |
AAC |
0.16 |
2e-05 |
| mRNA |
Rapamycin |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
3e-05 |
| mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
4e-05 |
| mRNA |
GSK1120212 |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
4e-05 |
| mRNA |
Sunitinib |
GDSC1000 |
pan-cancer |
AAC |
0.22 |
7e-05 |
| mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
7e-05 |
| mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
8e-05 |
| mRNA |
PLX4720 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
8e-05 |
| mRNA |
PD-0325901 |
gCSI |
pan-cancer |
AAC |
0.22 |
9e-05 |
| mRNA |
Docetaxel |
GDSC1000 |
pan-cancer |
AAC |
0.14 |
0.0001 |